Your browser doesn't support javascript.
loading
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy.
Awasthi, Niranjan; Schwarz, Margaret A; Zhang, Changhua; Klinz, Stephan G; Meyer-Losic, Florence; Beaufils, Benjamin; Thiagalingam, Arunthathi; Schwarz, Roderich E.
Afiliação
  • Awasthi N; Department of Surgery, Indiana University School of Medicine, South Bend, Indiana.
  • Schwarz MA; Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana.
  • Zhang C; Harper Cancer Research Institute, University of Notre Dame, South Bend, Indiana.
  • Klinz SG; Department of Pediatrics, Indiana University School of Medicine, South Bend, Indiana.
  • Meyer-Losic F; Department of Gastrointestinal Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Guangming, Shenzhen, China.
  • Beaufils B; Ipsen Bioscience, Cambridge, Massachusetts.
  • Thiagalingam A; Ipsen Innovation, Les Ulis, France.
  • Schwarz RE; Ipsen Innovation, Les Ulis, France.
Mol Cancer Ther ; 21(7): 1149-1159, 2022 07 05.
Article em En | MEDLINE | ID: mdl-35500018
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Gástricas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2022 Tipo de documento: Article